Previous close | 30.49 |
Open | 30.48 |
Bid | 31.18 x 1000 |
Ask | 31.19 x 1100 |
Day's range | 30.24 - 31.28 |
52-week range | 25.77 - 40.28 |
Volume | |
Avg. volume | 1,999,277 |
Market cap | 4.235B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.03 |
Earnings date | 07 May 2024 |
Forward dividend & yield | 1.10 (3.59%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | 40.50 |
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT).
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]
Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.